With sadness in our hearts, we inform that our dear colleague and friend Ralf Jutvik passed away during Christmas. Ralf had a quiet ending without pain and with his loved ones at his side. With astonishing 72 years in the field of analytical chemistry Ralf was truly unique. His exceptional and successful international career is almost impossible to summarize. With extraordinary enthusiasm, curiosity and leadership he started many new businesses around the world. During his 28 years at Perkin Elmer Ralf started offices in for example Moscow, Hongkong and China.

Most people start to slow down the pace when reaching their retirement age, but not Ralf. Instead, he began a new impressive journey as a serial entrepreneur in the life science field. Amongst his engagements Jour Research AB and SeQuant AB can be mentioned, both later sold to Valco and Merck, respectively. Ralf’s last major project was Biotech AB, which since the foundation 15 years ago has transformed from a small start-up to become an important global supplier of fluidic components to leading instrument manufacturers and distributors, with offices in the US and Japan and sales to 40 countries.

The Biotech Team, around the world, will miss Ralf’s enthusiasm, never-ending positivity and the warmness he always spread, even after his retirement in July this year, at an age of 95 years. In the spirit of Ralf, we will continue the journey.

Fritiof Pontén                             Anders Grahn
CEO, Biotech AB                        Chairman of the Board & Founder, Biotech AB